pressurised metered dose inhalers (pMDIs) [Regulatives / Guidelines]

posted by Mahesh M – India, 2014-09-12 10:46 (3512 d 16:57 ago) – Posting: # 13493
Views: 2,364

Dear All,
My concern is about Pharmacokinetic parameters for pressurised metered dose inhalers (pMDIs) EMA submission Study.

As per the guideline http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003504.pdf
London, 22 January 2009 Doc. Ref. CPMP/EWP/4151/00 Rev. 1 Section 6.1.1 (page no10.)

“In accordance with the standard accepted methods of assessment of bioequivalence the maximum concentration (Cmax), the area under the curve (AUC) and the time to Cmax (Tmax) should be compared.”

It means Bioequivalence depends on: Cmax. AUCt and Tmax?

Regards

Complete thread:

UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,656 registered users;
123 visitors (0 registered, 123 guests [including 3 identified bots]).
Forum time: 03:44 CEST (Europe/Vienna)

Never never never never use Excel.
Not even for calculation of arithmetic means.    Martin Wolfsegger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5